HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,160.00
+80.00 (2.60%)
Aug 14, 2026, 3:30 PM KST

HLB Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,47613,29152,72516,76930,97831,254
Short-Term Investments
5,273586.8816,21211,29812,35024,690
Trading Asset Securities
--10,62950,79388,66184,017
Cash & Short-Term Investments
19,74813,87879,56678,860131,989139,961
Cash Growth
-69.10%-82.56%0.90%-40.25%-5.70%-11.44%
Accounts Receivable
18,27714,97518,12011,46413,07211,648
Other Receivables
640.921,9062,0572,3712,1161,123
Receivables
19,92122,88420,18814,64616,20214,157
Inventory
5,8606,7916,1035,26710,8671,769
Prepaid Expenses
862.661,081468.69448.74208.4281.34
Other Current Assets
1,0081,0041,382238.851,509654.91
Total Current Assets
47,40045,637107,70999,460160,776156,822
Property, Plant & Equipment
130,531129,75381,20672,91892,08922,081
Long-Term Investments
231,085226,153254,694146,03844,74924,346
Goodwill
-8,275-1,77221,925-
Other Intangible Assets
51,24043,33844,78054,02969,50662,809
Long-Term Accounts Receivable
----341.17363.96
Long-Term Deferred Charges
-125.91----
Other Long-Term Assets
24,60124,67650,50049,15822,2644,262
Total Assets
485,003478,094539,017423,500411,790270,800

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,6062,6826,9855,1609,38410,278
Accrued Expenses
2,4992,8192,0292,240697.15717.82
Short-Term Debt
89,29184,72728,153106,7617,920-
Current Portion of Long-Term Debt
18,19418,38012,2767,060387.2-
Current Portion of Leases
650.16920.17632.14922.332,145668
Current Income Taxes Payable
92.36177.5352.67,555132.13-
Current Unearned Revenue
--2.9131.4938.4224.01
Other Current Liabilities
15,7739,1113,4175,7276,0811,848
Total Current Liabilities
129,106118,81553,547135,45726,78513,536
Long-Term Debt
53,91754,47382,52951,410136,1893,500
Long-Term Leases
2,0131,857193.33424.01832.41452.62
Pension & Post-Retirement Benefits
746.21709.14568.2615.57683.58716.65
Long-Term Deferred Tax Liabilities
2,9212,2082,3103,34510,0335,758
Other Long-Term Liabilities
2,3182,2881,0451,0361,201224.73
Total Liabilities
191,023180,351140,192192,288175,72424,188

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
61,43261,43261,41651,40748,83148,223
Additional Paid-In Capital
320,197320,197319,343168,141222,910240,895
Retained Earnings
-91,212-83,41616,37310,431-40,963-46,832
Treasury Stock
-679.97-679.97-679.97-679.97--
Comprehensive Income & Other
3,863-1821,8891,4993,9473,904
Total Common Equity
293,601297,351398,340230,797234,725246,189
Minority Interest
379.68390.84484.91416.211,342422.87
Shareholders' Equity
293,981297,742398,825231,213236,067246,612
Total Liabilities & Equity
485,003478,094539,017423,500411,790270,800

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
164,066160,357123,783166,578147,4734,621
Net Cash (Debt)
-144,318-146,479-44,217-87,718-15,484135,340
Net Cash Growth
------7.71%
Net Cash Per Share
-1183.35-1201.75-396.21-861.84-153.361362.33
Filing Date Shares Outstanding
121.85121.85121.81101.896.71100.44
Total Common Shares Outstanding
121.85121.85121.81101.8101.71100.44
Working Capital
-81,706-73,17954,162-35,997133,991143,286
Book Value Per Share
2409.582440.363270.062267.232307.672451.22
Tangible Book Value
242,361245,738353,561174,996143,294183,380
Tangible Book Value Per Share
1989.052016.782902.451719.071408.781825.85
Land
-27,49021,56921,47129,5809,065
Buildings
-51,36223,22123,22119,9504,547
Machinery
-75,80540,05639,21930,94912,906
Construction In Progress
-1,24333,1018,47218,3901,324